Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Geography Still Sets the Stage. Geoeconomics Now Runs the Show.

Introduction: A Shift in How Power Is Exercised

Nitish Kishor | 20 April 2026

War's Uneven Ledger: How Conflict Silently Redistributes Global Wealth

The Destruction Column and the One Nobody Reads

Nitish Kishor | 20 April 2026

Datadog (DDOG) Shows Early Recovery Signs: Reclaim of Key Averages Signals Improving Momentum

DDOG appears to be transitioning from a clear downtrend into a stabilization phase.

Nitish Kishor | 20 April 2026

U.S.-Iran Ceasefire Fractures as Gulf Seizure Sends Oil and Futures Markets Reeling

Monday was shaped by two converging developments: a U.S. naval seizure of an Iranian-flagged cargo vessel and the effective collapse of planned peace negotiations. Both carried immediate and measurable consequences for energy and equity markets.

Nitish Kishor | 20 April 2026

Satellite Broadband's Capital Race: SpaceX's IPO Meets Amazon Leo's Structural Challenge

SpaceX has confidentially filed for an IPO with the SEC, targeting a $75 billion raise at a valuation above $2 trillion, with a June 2026 Nasdaq listing anticipated. If it holds, this would be the largest public offering in history, surpassing Saudi Aramco's 2019 …

Ankur Sharma | 20 April 2026

USA Rare Earth's  (NASDAQ:USAR) $2.8 Billion Serra Verde Acquisition Targets China's Rare Earth Dominance

USA Rare Earth (NASDAQ:USAR) acquires Brazil's Serra Verde Group for $2.8 billion in a landmark deal creating the only scaled non-Asian producer of all four magnetic rare earths, backed by U.S. government offtake and $3.2 billion in pro-forma liquidity.Key HighlightsUSA Rare Earth signs definitive …

Nitish Kishor | 20 April 2026

Beats, Misses and the $17 Billion Divide: What Q1 Earnings Are Really Telling Us

Companies reported:38 companies across 10+ sectors

Nitish Kishor | 20 April 2026

Trump Executive Order Drives Psychedelic Biotech Rally

US biotechnology stocks rallied after President Donald Trump signed an executive order directing federal agencies to prioritise the development and approval of psychedelic-assisted therapies. The directive, issued in Washington, seeks to streamline regulatory pathways, expand research funding, and improve patient access to treatments historically …

Nitish Kishor | 20 April 2026
Support

Hi! How can we help you today?

Loading…